Last deal

$2M

Amount

Venture - Series Unknown

Stage

06.03.2015

Date

1

all rounds

$2M

Total amount

General

About Company
Induce Biologics develops cost-effective bioimplants for bone regeneration.

Industry

Sector :

Subsector :

founded date

01.01.2008

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The company's lead product, URIST, is a game-changing bone regeneration solution that uses a proprietary carrier to deliver Bone Morphogenetic Protein (BMP) in an easy-to-use putty form. Unlike other products on the market, URIST's multiphasic delivery technology allows for more efficient bone formation with less BMP, reducing costs and improving effectiveness. By replicating the body's natural healing capabilities, Induce Biologics aims to provide affordable solutions that optimize handling, reduce the need for additional surgeries, and improve healing times for patients in need of bone repair or fusion.
Contacts

Phone number

Social url